This study was undertaken to evaluate the cyclic adenosine monophosphate (cAMP) binding proteins in the cerebral cortex of rat after short- and long-term administration with antidepressants. Prolonged treatment with different antidepressants that inhibit serotonin or norepinephrine uptake such as fluoxetine and the (+) enantiomer of oxaprotiline, respectively, was able to induce an increase in the photoactivated incorporation of 8-N3-[P-32]cAMP into a protein band with apparent molecular weight of 52,000 in both soluble and crude microtubule fraction. On the contrary, chronic treatment with the (-) enantiomer of oxaprotiline, which does not affect monoamine uptake, failed to produce this effect. Moreover, no changes were observed after acute or in vitro addition of antidepressants, suggesting that modification in the cAMP binding may be related to adaptive changes elicited by prolonged antidepressants treatment. In conclusion, our studies indicate that the cAMP binding protein associated with the crude microtubule fraction could be an intracellular target for the action of antidepressant drugs.

CAMP BINDING-PROTEINS IN THE RAT CEREBRAL-CORTEX AFTER ADMINISTRATION OF SELECTIVE 5-HT AND NE REUPTAKE BLOCKERS WITH ANTIDEPRESSANT ACTIVITY / J. PEREZ, D. TINELLI, E. BIANCHI, N. BRUNELLO, G. RACAGNI. - In: NEUROPSYCHOPHARMACOLOGY. - ISSN 0893-133X. - 4:1(1991), pp. 57-64.

CAMP BINDING-PROTEINS IN THE RAT CEREBRAL-CORTEX AFTER ADMINISTRATION OF SELECTIVE 5-HT AND NE REUPTAKE BLOCKERS WITH ANTIDEPRESSANT ACTIVITY

G. RACAGNI
1991

Abstract

This study was undertaken to evaluate the cyclic adenosine monophosphate (cAMP) binding proteins in the cerebral cortex of rat after short- and long-term administration with antidepressants. Prolonged treatment with different antidepressants that inhibit serotonin or norepinephrine uptake such as fluoxetine and the (+) enantiomer of oxaprotiline, respectively, was able to induce an increase in the photoactivated incorporation of 8-N3-[P-32]cAMP into a protein band with apparent molecular weight of 52,000 in both soluble and crude microtubule fraction. On the contrary, chronic treatment with the (-) enantiomer of oxaprotiline, which does not affect monoamine uptake, failed to produce this effect. Moreover, no changes were observed after acute or in vitro addition of antidepressants, suggesting that modification in the cAMP binding may be related to adaptive changes elicited by prolonged antidepressants treatment. In conclusion, our studies indicate that the cAMP binding protein associated with the crude microtubule fraction could be an intracellular target for the action of antidepressant drugs.
caMP binding protein; frontal cortex; antidepressants
Settore BIO/14 - Farmacologia
NEUROPSYCHOPHARMACOLOGY
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/185064
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 65
  • ???jsp.display-item.citation.isi??? 65
social impact